Sorry, you need to enable JavaScript to visit this website.

Sign Up For Mailing List Button

Disease Search Button

NETS - Health Authorities

Facebook icon
Twitter icon
LinkedIn icon
  • Partnerships
  • Publications
  • Multimedia
  • Worksheets
  • Guides
  • Toolkits
  • Databases
  • Services

What are health authorities' reporting meeting and amendment procedures, and why are they important in drug development?

In the United States, FDA reporting meetings are conducted after the completion of an IND application but prior to the official ruling on an NDA. They provide the sponsor with the opportunity to discuss their application with regulatory officials and make the necessary updates. Members of the community, including patients, advocates, and researchers, are also allowed to offer their perspective on an investigational compound to regulatory officials.

Testimonials: How we did it

Content not yet available for this section.

Relevant Publications

Content not yet available for this section.

Related Tools

Content not yet available for this section.

Follow Us

Twitter icon
Facebook icon
LinkedIn icon
YouTube icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.